Risk factors for post-thrombotic syndrome in patients with deep vein thrombosis: from the COMMAND VTE registry

[1]  Takeshi Kimura,et al.  Anticoagulation Therapy for Venous Thromboembolism in the Real World　- From the COMMAND VTE Registry. , 2018, Circulation journal : official journal of the Japanese Circulation Society.

[2]  S. Goldhaber,et al.  Pharmacomechanical Catheter‐Directed Thrombolysis for Deep‐Vein Thrombosis , 2017, The New England journal of medicine.

[3]  P. Prandoni,et al.  The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. , 2014, Circulation.

[4]  Christina Holcroft,et al.  Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial , 2014, The Lancet.

[5]  P. Prandoni,et al.  Association between thrombophilia and the post‐thrombotic syndrome: a systematic review and meta‐analysis , 2014, Journal of thrombosis and haemostasis : JTH.

[6]  P. Prandoni,et al.  Residual vein thrombosis and trans-popliteal reflux in patients with and without the postthrombotic syndrome , 2013, Thrombosis and Haemostasis.

[7]  S. Kahn,et al.  Predictors of post‐thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency , 2013, Journal of thrombosis and haemostasis : JTH.

[8]  J. Chen,et al.  Postthrombotic morbidity correlates with residual thrombus following catheter-directed thrombolysis for iliofemoral deep vein thrombosis. , 2012, Journal of vascular surgery.

[9]  Elie A Akl,et al.  Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. , 2012, Chest.

[10]  Paolo Prandoni,et al.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[11]  D. Lamping,et al.  Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation , 2011, Journal of thrombosis and haemostasis : JTH.

[12]  K. Rothman,et al.  Non‐steroidal anti‐inflammatory drug use and risk of venous thromboembolism , 2011, Journal of thrombosis and haemostasis : JTH.

[13]  J. Kline,et al.  Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). , 2011, Journal of the American College of Cardiology.

[14]  F. Rosendaal,et al.  Risk assessment for recurrent venous thrombosis , 2010, The Lancet.

[15]  A. Iorio,et al.  Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review. , 2010, Archives of internal medicine.

[16]  A. Gasparis,et al.  Recurrent Deep Vein Thrombosis: Long-Term Incidence and Natural History , 2010, Annals of surgery.

[17]  F. Rosendaal,et al.  Risk factors for post‐thrombotic syndrome in patients with a first deep venous thrombosis , 2008, Journal of thrombosis and haemostasis : JTH.

[18]  D. Lamping,et al.  Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. , 2008, Annals of internal medicine.

[19]  S. Kahn,et al.  Postthrombotic syndrome in relation to vena cava filter placement: a systematic review. , 2008, Journal of vascular and interventional radiology : JVIR.

[20]  D. Lamping,et al.  Determinants of health‐related quality of life during the 2 years following deep vein thrombosis , 2008, Journal of thrombosis and haemostasis : JTH.

[21]  C. Thalhammer,et al.  Effect of prolonged treatment with compression stockings to prevent post-thrombotic sequelae: a randomized controlled trial. , 2008, Journal of vascular surgery.

[22]  G. Moneta,et al.  The hemodynamics and diagnosis of venous disease. , 2007, Journal of vascular surgery.

[23]  E. Oger,et al.  Venous thromboembolism (VTE) in Europe , 2007, Thrombosis and Haemostasis.

[24]  M. Nozaki,et al.  High peak reflux velocity in the proximal deep veins is a strong predictor of advanced post‐thrombotic sequelae , 2007, Journal of thrombosis and haemostasis : JTH.

[25]  O. Linder,et al.  Post‐thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months , 2006, Journal of thrombosis and haemostasis : JTH.

[26]  E. Minar,et al.  The post‐thrombotic syndrome: risk factors and impact on the course of thrombotic disease , 2005, Journal of thrombosis and haemostasis : JTH.

[27]  M. Heijer,et al.  The post-thrombotic syndrome: incidence and prognostic value of non-invasive venous examinations in a six-year follow-up study , 2005, Thrombosis and Haemostasis.

[28]  M. Prins,et al.  Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome , 2005, Journal of thrombosis and haemostasis : JTH.

[29]  P. Prandoni,et al.  Vein abnormalities and the post‐thrombotic syndrome , 2005, Journal of thrombosis and haemostasis : JTH.

[30]  J. Cameron,et al.  Five-year outcome study of deep vein thrombosis in the lower limbs. , 2004, Journal of vascular surgery.

[31]  M Gent,et al.  Prevention and treatment of postphlebitic syndrome: results of a 3-part study. , 2001, Archives of internal medicine.

[32]  M. A. van 't Hof,et al.  The postthrombotic syndrome in relation to venous hemodynamics, as measured by means of duplex scanning and strain-gauge plethysmography. , 1999, Journal of vascular surgery.

[33]  Samuel Z Goldhaber,et al.  Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) , 1999, The Lancet.

[34]  P. Ridker,et al.  Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. , 1997, JAMA.

[35]  Paolo Prandoni,et al.  The Long-Term Clinical Course of Acute Deep Venous Thrombosis , 1996, Annals of Internal Medicine.

[36]  F R Rosendaal,et al.  A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy , 1993, Thrombosis and Haemostasis.

[37]  Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009). , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[38]  S. Laporte,et al.  Thromboembolism : Findings From the Registro Informatizado de la Enfermedad Clinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous , 2008 .